Clinical Trial Update: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis [Phase 3]

View source ↗

Summary

The MOBILE study, a Phase 3 trial evaluating regimens of Bonviva (ibandronate) in postmenopausal osteoporosis, has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Post Menopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2016-05-30